Volume 71, Issue 3 , Pages 143-146, March 2008
Cidofovir Injection for Recurrent Laryngeal Papillomatosis
Article Outline
Background
Recurrent laryngeal papillomatosis is caused by the human papilloma virus and characterized by multiple exophytic lesions of the vocal tract; it is a benign disease, but one that tends to recur after removal of growths. Due to the nature of the disease, alternative treatment strategies have focused on antiviral injection at lesion sites that eliminate repeated surgical procedures. The purpose of this study was to evaluate the efficacy of cidofovir injection following initial papilloma excision with a microdebrider.
Methods
Cidofovir injections (at a concentration of 7.5 mg/mL) were conducted in 5 patients (1 child; 4 adults). The injection number per patient varied from 2 mL to 6 mL. Repeated cidofovir injections were indicated only if recurrent or newly grown lesions were found in any of 3-week follow-up visits.
Results
Short-term complete remission was observed with different duration, from 11 to 21 weeks, following initial 2 to 3 cidofovir injections. All patients relapsed eventually, and their recurrent lesions were not successfully eradicated by repeated cidofovir injection. One patient's prognosis was complicated by scarring of both vocal cords.
Conclusion
Surgical excision combined with cidofovir injection failed to prevent relapsing laryngeal papillomatosis. Once lesions recurred, repeated cidofovir injections alone were not able to achieve complete remission, although these procedures might be helpful in lessening the severity of the clinical course. Further studies in determining the dosage, duration of injection, and more long-term follow-up are required to clarify the efficacy of cidofovir for the treatment of recurrent laryngeal papillomatosis.
Key Words: cidofovir , larynx , papilloma , surgery
No full text is available. To read the body of this article, please view the PDF online.
References
- . Current diagnostic and management trends for recurrent respiratory papillomatosis . Curr Opin Otolaryngol Head Neck Surg . 2004;12:532–537
- . Recurrent respiratory papillomatosis . Laryngoscope . 2001;111:57–69
- . Overview of recurrent respiratory papillomatosis . Curr Opin Otolaryngol Head Neck Surg . 2003;11:433–441
- Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial . Ann Intern Med . 1997;126:257–263
- . Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir . Laryngoscope . 2003;113:1583–1587
- . Intralesional cidofovir and surgical excision for laryngeal papillomato-sis . Laryngoscope . 2003;113:2174–2181
- . A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir . Arch Otolaryngol Head Neck Surg . 2003;129:1081–1085
- . Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis . J Voice . 2004;18:551–556
- . Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? . Int J Pediatr Otorhinolaryngol . 2004;68:413–418
- . A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis . Laryngoscope . 1998;108:935–937
- . Recurrent respiratory papillomatosis: juvenile versus adult forms . Laryngoscope . 1994;104:523–527
- . American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy . Arch Otolaryngol Head Neck Surg . 2004;130:1039–1042
- . Treatment of severe laryngeal papil-lomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine] . J Med Virol . 1998;54:219–225
PII: S1726-4901(08)70006-6
doi:10.1016/S1726-4901(08)70006-6
© 2008 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 71, Issue 3 , Pages 143-146, March 2008
